These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1524656)

  • 1. PET scanning in schizophrenia, a critical evaluation. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Murphy D; Rapoport SI
    Neuropsychopharmacology; 1992 Aug; 7(1):59-61; discussion 73-5. PubMed ID: 1524656
    [No Abstract]   [Full Text] [Related]  

  • 2. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Wong DF
    Neuropsychopharmacology; 1992 Aug; 7(1):69-72; discussion 73-5. PubMed ID: 1388023
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Buchsbaum MS
    Neuropsychopharmacology; 1992 Aug; 7(1):67-8; discussion 73-5. PubMed ID: 1355970
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Seeman P
    Neuropsychopharmacology; 1992 Aug; 7(1):55-7; discussion 73-5. PubMed ID: 1388022
    [No Abstract]   [Full Text] [Related]  

  • 5. The current status of PET scanning with respect to schizophrenia.
    Sedvall G
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitters are important, but so is metabolism. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Gur RE; Gur RC
    Neuropsychopharmacology; 1992 Aug; 7(1):63-5; discussion 73-5. PubMed ID: 1355969
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo neuropharmacology of schizophrenia.
    Bigliani V; Pilowsky LS
    Br J Psychiatry Suppl; 1999; (38):23-33. PubMed ID: 10884897
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of anti-psychotic agents on brain glucose metabolism and regional cerebral circulation in patients with schizophrenia-- study by functional brain imaging of SPECT and PET].
    Jibiki I
    Seishin Shinkeigaku Zasshi; 2002; 104(2):144-51. PubMed ID: 11985069
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural and functional brain imaging in schizophrenia.
    Cleghorn JM; Zipursky RB; List SJ
    J Psychiatry Neurosci; 1991 Jul; 16(2):53-74. PubMed ID: 1911736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia.
    Buchsbaum MS; Potkin SG; Marshall JF; Lottenberg S; Teng C; Heh CW; Tafalla R; Reynolds C; Abel L; Plon L
    Neuropsychopharmacology; 1992 May; 6(3):155-63. PubMed ID: 1599606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography scans in schizophrenia.
    Pal H; Saxena S
    Natl Med J India; 1994; 7(2):74. PubMed ID: 8019402
    [No Abstract]   [Full Text] [Related]  

  • 12. Haloperidol blocks the uptake of [18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients.
    Yousef KA; Volkow ND; Schlyer DJ; Fowler JS; Wolf AP; Wang GJ; Smith MR; Brodie JD; Warner D
    Synapse; 1995 Jan; 19(1):14-7. PubMed ID: 7709339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical brain anatomy in schizophrenia.
    Sedvall G; Farde L
    Lancet; 1995 Sep; 346(8977):743-9. PubMed ID: 7658878
    [No Abstract]   [Full Text] [Related]  

  • 14. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
    Farde L; Hall H
    Arzneimittelforschung; 1992 Feb; 42(2A):260-4. PubMed ID: 1316756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of the D2 dopamine receptor in schizophrenia as studied with PET.
    Wiesel FA
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():460A-461A. PubMed ID: 1354050
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography].
    M'Rabet N; Lotstra F; Goldman S; Delvenne V; Mendlewicz J
    Acta Psychiatr Belg; 1991; 91(6):311-26. PubMed ID: 1670424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectral signature method for the analysis of PET brain images.
    Levy AV; Laska E; Brodie JD; Volkow ND; Wolf AP
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):A103-13. PubMed ID: 1997478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of positron emission tomography research for the investigation of the actions of antipsychotic drugs.
    List SJ; Cleghorn JM
    Br J Psychiatry Suppl; 1993 Dec; (22):25-30. PubMed ID: 7906522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients.
    Farde L; Nordström AL; Nyberg S; Halldin C; Sedvall G
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():67-9. PubMed ID: 7961577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Searching for the neuropathology of schizophrenia: neuroimaging strategies and findings.
    Lieberman JA
    Am J Psychiatry; 1999 Aug; 156(8):1133-6. PubMed ID: 10450250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.